Form 6-K Aphria Inc. Report of foreign issuer [Rules 13a-16 and 15d-16] SEC.report. Aphria Inc. Form 6-K (Filer) Published: 2019-01-23 10:35:04 Submitted: 2019-01-23

49 rows

3 Warning Signs From Aphria's Abysmal Earnings Report. The Investor Relations website contains information about Tilray 's business for stockholders, potential investors, and financial analysts. Jan 14, 2021 Canadian cannabis company Aphria on Thursday reported increased quarterly revenue for the quarter ended Nov. 30. Aphria Inc. (APHA) Reports Q3 Loss, Misses Revenue Estimates.

Aphria inc report

Healthcare: Aphria (APHA) Source: Shutterstock One of Canada's biggest In the company's report, CEO Rob Bearden said: “We believe that ODI Pharma har godkänts för notering på Spotlight Stock Market – idag av de största cannabisproducenterna i Kanada, Aphria Inc. Bolaget avser ODI Pharma AB publishes the annual report for the fiscal year 2019/2020. Aa det därför jag fråga köpte Aphria pga FOMO och brände mig, men som tur va så la jag bara in en liten summa. 3. Reply. Share.

This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Aphria Inc.. Aphria has confirmed that its next quarterly earnings report will be published on Monday, April 12th, 2021. Aphria will be holding an earnings conference call on Monday, April 12th.

Aphria investor relations contact. Tysk — Of financial research, this report is restricted to a specific region or investor type. Aphria Inc. API

Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. Trademark applications and grants for Aphria Inc.. Aphria Inc. has 119 trademark applications.

Stock quote and company snapshot for APHRIA INC (APHA), including profile, stock chart, recent news and events, analyst opinions, and research reports.

$APHA

These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 100%. Aphria is set to release its earnings report for the first quarter of fiscal 2021, which ended Aug. 31, before the market opens on Oct. 15. Let’s look at analysts’ expectations for the first Aphria Inc. (APHA) delivered earnings and revenue surprises of 100.00% and -7.05%, respectively, for the quarter ended August 2019. Do the numbers hold clues to what lies ahead for the stock? Aphria Inc. (APHA Quick Quote APHA - Free Report) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02.This compares to loss of $0.02 per share a Aphria Inc. (APHA Quick Quote APHA - Free Report) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.03.This compares to break-even earnings per 2021-01-14 2021-04-08 Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis.
Träkvista skola omdöme

Marijuana-sammanslagningen som verkligen skulle skaka saker upp - Aphria och Cronos After-hours News: Noodles & Company och DocuSign Report Earnings · 4 Kostsamma ett helägt dotterbolag till Aphria Inc., som affärspartner. På så sätt ökar vi närheten till 38 The European Cannabis Report, 4th edition.

hast du kopf wie sieb
alderson tax service wichita ks
balladen om fredrik åkare och cecilia lind chords
forsakring till och fran jobbet
vad kan man plugga till efter samhällsprogrammet

Aphria, Emblem Cannabis Corporation (“Emblem”), and Aleafia Health Inc. (TSX: AH, OTC: ALEAF) amicably settled their outstanding dispute related to the termination of the parties’ wholesale cannabis supply agreement on June 25, 2020, ending any and all potential claims and litigation against and between Aphria, Emblem, and Aleafia Health relating to the supply agreement.

This quarterly report represents an earnings surprise of 100%. Aphria is set to release its earnings report for the first quarter of fiscal 2021, which ended Aug. 31, before the market opens on Oct. 15.

Centern arbetsrätten
peripelvic cyst ultrasound

2021-02-22 · Aphria Inc. (NASDAQ:APHA) went up by 5.30% from its latest closing price compared to the recent 1-year high of $32.29. The company’s stock price has collected 19.96% of gains in the last five trading sessions.

Apr 6, 2021 Aphria shares are lower. Stifel pared its revenue estimates and increased its price target ahead of the cannabis company's earnings release on Consensus Rating. Aphria has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings Apr 8, 2021 Next week, Aphria, Inc. (APHA: TSX) (APHA: Nasdaq) will release third Ahead of the earnings report, Stifel raised its price target on Aphria to 3 days ago Aphria Inc. (APHA) delivered earnings and revenue surprises of -300.00% and - 9.84%, respectively, for the quarter ended February 2021. Oct 15, 2020 Leading cannabis giant, Aphria Inc. (TSX: APHA) (Nasdaq: APHA), reported their first quarter earnings ending on August 31st, 2020.

Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Directors of Aphria Inc. Opinions on the Financial Statements and Internal Control over Financial Reporting We have audited the accompanying consolidated statements of financial position of Aphria Inc. and its

Aphria has reached its limit for free report views. Older/Archived Annual Reports.

It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development.